VISUAL ACUITY OUTCOME AFTER INTRAVITREAL BEVACIZUMAB INJECTION IN RETINAL VEIN OCCLUSION

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

YAGHOOBI GHOLAMHOSSEIN; HEYDARI BEHROUZ; MEHDIZADAH BEHCET

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Medical Journal of Mashhad University of Medical Sciences Year:2016 | Volume:59 | Issue:1 Page(s): 41-47

Download Full-Text

Persian Verion

View:

667

Download:

Cites:

Information Journal Paper

Title

VISUAL ACUITY OUTCOME AFTER INTRAVITREAL BEVACIZUMAB INJECTION IN RETINAL VEIN OCCLUSION

Author(s)

YAGHOOBI GHOLAMHOSSEIN | HEYDARI BEHROUZ | MEHDIZADAH BEHCET | Issue Writer Certificate

Keywords

INTRAVITREAL INJECTIONQ1

VISUAL ACUITYQ2

RETINAL VEIN OCCLUSIONQ2

Abstract

Introduction: RETINAL VEIN OCCLUSION causes sudden visual loss and macular edema.Visual improvement after intravitreal Bevacizumab in recent years is argued in this study. To define the Bevacizumab effect on visual outome in RETINAL VEIN OCCLUSION.Methods: All attendants who had a diagnosis of RETINAL VEIN OCCLUSION after ophthalmic examination enrolled in this study. The logarithm of the vision set, before 1.25 mg Bevacizumab injected intravitrealy was compared with postoperative VISUAL ACUITY of log Mar of 1, 3 and 6 months after injection. The possible side effects of INTRAVITREAL INJECTION of Bevacizumab, after 1, 3 and 6 months were recorded. The Cross Kalvalys, Wilcoxon and Friedman rank correlation coefficients of a £0.05 were assessed in study.Results: The mean age of 39 patients was 60.70±10.9 years. The mean disease duration was 2.29±2.72 months. There was statistically significant difference in mean Log Mar VISUAL ACUITY regarding the duration of time. Mean VISUAL ACUITY before injection was 1.58 ± 0.81, a month after the injection 0.93±0.77, three months after the injection 1.16±0.97, and six months after injection, 1.27±1.Conclusion: The Bevacizumab has significant role in improving vision in patients with RETINAL VEIN OCCLUSION, although ocular complications after intraocular injection of Bevacizumab are far less than other similar approaches but few no responding occur which develop neovascular glaucoma.

Cites

No record.

References

Cite

APA: Copy

YAGHOOBI, GHOLAMHOSSEIN, HEYDARI, BEHROUZ, & MEHDIZADAH, BEHCET. (2016). VISUAL ACUITY OUTCOME AFTER INTRAVITREAL BEVACIZUMAB INJECTION IN RETINAL VEIN OCCLUSION. MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES, 59(1), 41-47. SID. https://sid.ir/paper/51538/en

Vancouver: Copy

YAGHOOBI GHOLAMHOSSEIN, HEYDARI BEHROUZ, MEHDIZADAH BEHCET. VISUAL ACUITY OUTCOME AFTER INTRAVITREAL BEVACIZUMAB INJECTION IN RETINAL VEIN OCCLUSION. MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2016;59(1):41-47. Available from: https://sid.ir/paper/51538/en

IEEE: Copy

GHOLAMHOSSEIN YAGHOOBI, BEHROUZ HEYDARI, and BEHCET MEHDIZADAH, “VISUAL ACUITY OUTCOME AFTER INTRAVITREAL BEVACIZUMAB INJECTION IN RETINAL VEIN OCCLUSION,” MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES, vol. 59, no. 1, pp. 41–47, 2016, [Online]. Available: https://sid.ir/paper/51538/en

Related Journal Papers